Characteristics of pneumonia in children with suspected/confirmed COVID-19
Abstract
Background The most common COVID-19 infection clinical features in pediatric patients are similar to those of other pulmonary diseases, i.e., fever, cough, and shortness of breath. Information about the characteristics of coinfection and superinfection in COVID-19 cases can reduce misdiagnosis and differentiate COVID-19 from other pulmonary infections.
Objective To observe the characteristics of pneumonia in children with suspected/confirmed COVID-19.
Methods This descriptive study used medical record data of children hospitalized from 1 January 2020 – 31 January 2021 to describe the characteristics of pneumonia in suspected and
confirmed COVID-19 cases in Haji Adam Malik Hospital, Medan, North Sumatra. Pneumonia-related findings, such as clinical symptoms, chest X-ray, and blood test results,were collected.
Results There were 27 confirmed and 34 suspected COVID-19 children. Most of them were aged 6 to 8 years. Pneumonia was significantly associated with COVID-19. In confirmed COVID-19 cases, fever persisted after 3 days, with cough and shortness of breath. Patients did not have flu symptoms, but had below normal SpO2 (81-90%). The occurrence of lung rhonchi was significant in confirmed COVID-19 group. Chest X-ray results showed lung opacity in all confirmed COVID-19 patients. Mean white blood cell (WBC) count was significantly lower in COVID-19 confirmed (3.49x103/µL) vs. suspected group (17.9 x103/µL) (P=0.011). Mean CRP was significantly higher in COVID-19 confirmed (26.5 mg/L) vs. suspected group (4 mg/L).
Conclusion Pneumonia with confirmed COVID-19 cases present with longer fever and lower SpO2. Patients are presented with lung ronchi, had lower WBCcount, and higher CRP. Chest X-ray shows opacity and consolidation.
References
2. Hasan A, Mehmood N, Fergie J. Coronavirus Disease (COVID-19) and pediatric patients: a review of epidemiology, symptomatology, laboratory and imaging results to guide the development of a management algorithm. Cureus. 2020;12:1-6. DOI: https://doi.org/10.7759/cureus.7485.
3. WHO. Coronavirus disease (COVID-19). 2020. [cited 2020 November 5]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf.
4. Bellino S, Punzo O, Rota MC, Manso MD, Urdiales AM, Andrianou X, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics. 2020;146:1-10. DOI: https://doi.org/10.1542/peds.2020-009399
5. Rabinowicz S, Leshem E, Pessach IM. COVID-19 in the pediatric population-review and current evidence. Curr Infect Dis Rep. 2020;22:1-12. DOI: https://doi.org/10.1007/s11908-020-00739-6.
6. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19. Ped Infect Dis J. 2020;39:355-68. DOI: https://doi.org/10.1097/INF.0000000000002660.
7. Sharma R, Agarwal M, Gupta M, Somendra S, Saxena SK. Clinical characteristics and differential clinical diagnosis of novel coronavirus disease 2019 (COVID-19). Coronavirus Disease 2019 (COVID-19). 2020;55–70. DOI: https://doi.org/10.1007/978-981-15-4814-7_6
8. Sahu KK, Mishra AK, Martin K, Chastain I. COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy. Curr Infect Dis Rep. 2020;90:246-7. DOI: https://doi.org/10.4081/monaldi.2020.1327
9. Chi Q, Dai X, Jiang, X, Zhu L, Du J, Chen Y, et al. Differential diagnosis for suspected cases of coronavirus disease 2019: a retrospective study. BMC Infect Dis. 2020;20:1-8 DOI: https://doi.org/10.1186/s12879-020-05383-y
10. Grimaud E, Challiol M, Guilbaud C, Delestrain C, Madhi F, Ngo J, et al. Delayed acute bronchiolitis in infants hospitalized for COVID?19. Wiley. 2020;1-2. DOI: https://doi.org/10.1002/ppul.24946.
11. Zare-Zardini H, Soltaninejad H, Ferdosian F, Hamidieh AA, Memarpoor-Yazdi M. Coronavirus disease 2019 (COVID-19) in children: prevalence, diagnosis, clinical symptoms, and treatment. Int J Gen Med. 2020;13:477-82. DOI : https://doi.org/10.2147/IJGM.S262098
12. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. [cited 2020 November 5]. Available from: https://www.covid19treatmentguidelines.nih.gov/.
13. Liu KC, Xu P, Lv WF, Chen L, Qiu XH, Yao JL, et al. Differential diagnosis of coronavirus disease 2019 from community-acquired-pneumonia by computed tomography scan and follow-up. Infect Dis Poverty. 2020;9:1-11. DOI: https://doi.org/10.1186/s40249-020-00737-9
14. Ebeledike C, Ahmad T. Pediatric Pneumonia. [Updated 2020 Aug 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. [cited 2020 November 5]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536940/.
15. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). 2020. [cited 2020 November 5]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html.
16. Sandora TJ, Sectish TC. Community-acquired pneumonia. In: Kliegman RM, Stanton BF, Geme JW, Schor NF, Behrman RE. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 1474-8. DOI: https://doi.org/10.14238/pi55.5.2015.248-51
17. Yasuhara J, Kuno T, Takagi H, Sumitomo N. Clinical characteristics of COVID?19 in children: a systematic review. Pediatric Pulmonology. 2020;55:2565-75. DOI: https://doi.org/10.1002/ppul.24991.
18. Kulkarni R, Rajput U, Dawre R, et al. Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission. Infection. 2021;49(2):339-343. DOI: https://doi.org/10.1007/s15010-020-01493-6.
19. Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeiter F, dkk. COVID-19 in7780 pediatric patients: a systematic review. EclinicalMedicine. 2020. DOI:10.1016/j.eclinm, 100433.2020.
20. Komisi Kesehatan Nasional dan Kantor Administrasi Nasional Pengobatan Tradisional Cina. Rekomendasi Nasional untuk Diagnosis dan Pengobatan Pneumonia yang disebabkan oleh SARS-CoV-2 (edisi ke-4). 2020.
Copyright (c) 2023 Rizal Marubob Silalahi, Wisman Dalimunthe, Rita Evalina, Juliandi HArahap, Bidasari Lubis, Inke Nadia D. Lubis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2023-04-10
Published 2023-04-11